ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

NTP Board Gives Concept Approvals

December 4, 1981

CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval

June 11, 1982

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

Organ Site Report On Pancreas Project, Breast cancer TF

May 7, 1976

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

June 10, 1988